We live in an era where finding answers quickly is highly valued. But is faster always better?
91 groups, individuals praise bipartisan Alzheimer’s-related efforts in Senate
By
Lois A. Bowers
Dec 14, 2020
Twenty-seven organizations and 64 individuals told Sens. Pat Toomey (R-PA) and Debbie Stabenow (D-MI) that they are “particularly encouraged” by the lawmakers’ recommendation that the Center for...
Navigating insurance for those with dementia a major challenge for family caregivers
By
Kathleen Steele Gaivin
Jan 30, 2024
Family caregivers face many challenges in helping their loved ones who are living with dementia, not the least of which is navigating the insurance landscape for long-term care. That’s according to the...
More news for Thursday, Jan. 26
Jan 25, 2017
Gene-blocking therapy reverses Alzheimer’s-like symptoms … New bill would increase temp worker protections … Projected $10 trillion federal debt growth over next decade may affect plans...
Senators formulate plan to address chronic illness in Medicare beneficiaries
By
Lois A. Bowers
Oct 30, 2016
Improving health outcomes and reducing Medicare costs related to beneficiaries with chronic conditions such as Alzheimer’s disease, diabetes and heart disease are the goals of a bipartisan proposal...
UCSF telehealth program cuts costs and improves outcomes for seniors with dementias
By
Aaron Dorman
Sep 25, 2023
A telehealth program out of UCSF has achieved the coveted goal of cutting costs and improving patient care for seniors with dementia, researchers state.
Advocates ‘appalled’ as CMS again says it will not cover monoclonal antibody treatments for Alzheimer’s
By
Kimberly Bonvissuto
Feb 24, 2023
Advocates of those living with Alzheimer’s disease are expressing disappointment that the Centers for Medicare & Medicaid Services on Wednesday rejected a request to expand its coverage of monoclonal...
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Lawmakers turn up heat on CMS to expand access to Alzheimer’s treatments
By
Kimberly Bonvissuto
Apr 28, 2023
Medicare needs to reconsider its national coverage decision on FDA-approved Alzheimer’s drug treatments, bipartisan members of the House told Centers for Medicare & Medicaid Services Administrator Chiquita...
More news for Wednesday, May 3
May 02, 2017
GAO testifies on Medicaid personal care services … Two will stand trial in death of resident with Alzheimer’s … For two college students, saying goodbye won’t be easy after a year...